Nitazoxanide for the empiric treatment of pediatric infectious diarrhea

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 106, Issue 3, 2012, Pages 167-173

  Rossignol, Jean François ^a,b   Lopez Chegne, Nicolas ^c   Julcamoro, Luis Martin ^c   Carrion, Maria E ^b   Bardin, Matthew C ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Romark Institute for Medical Research   (United States)

^c Regional Hospital of Cajamarca   (Peru)

Author keywords

Diarrhea; Gastroenteritis; Giardia; Nitazoxanide; Protozoa; Rotavirus

Indexed keywords

NITAZOXANIDE;

ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GIARDIASIS; HUMAN; INFANT; INFECTIOUS DIARRHEA; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE;

ANTIPARASITIC AGENTS; CHILD; CHILD, PRESCHOOL; DIARRHEA; DOUBLE-BLIND METHOD; FEMALE; GASTROENTERITIS; GIARDIA LAMBLIA; HISPANIC AMERICANS; HUMANS; INFANT; MALE; PERU; THIAZOLES; TREATMENT OUTCOME;

GIARDIA; GIARDIA INTESTINALIS; PROTOZOA; ROTAVIRUS;

EID: 84857064067     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2011.11.007     Document Type: Article

References (33)

1. Boschi-Pinto C., Velebit L., Shibuya K. Estimating child mortality due to diarrhea in developing countries. Bull World Health Organ 2008, 86:710-717.
2. Parashar U.D., Hummelman E.G., Bresee J.S., Miller M.A., Glass R.I. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003, 9:565-572.
3. Guerrant D.I., Moore S.R., Lima A.A., Patrick P.D., Schorling J.B., Guerrant R.L. Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function 4-7 years later in a poor urban community in Northern Brazil. Am J Trop Med Hyg 1999, 61:707-713.
4. Charles M.D., Holman R.C., Curns A.T., Parashar U.D., Glass R.I., Bresee J.S. Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002. Pediatr Infect Dis J 2006, 25:489-493.
5. Olesen B., Neimann J., Bottiger B., Ethelberg S., Schiellerup P., Jensen C., et al. Etiology of diarrhea in young children in Denmark: a case-control study. J Clin Microbiol 2005, 43:3636-3641.
6. Junquera C.G., Sainz de Baranda C., Mialdea O.G., Serrano E.B., Sanchez-Fauquier A. Prevalence and clinical characteristics of norovirus gastroenteritis among hospitalized children in Spain. Pediatr Infect Dis J 2009, 28:604-607.
7. Lorrot M., Bon F., El Hajje M.J., Aho S., Wolfer M., Giraudon H., et al. Epidemiology and clinical features of gastroenteritis in hospitalised children: prospective survey during a 2-year period in a Parisian hospital, France. Eur J Clin Microbiol Infect Dis 2011, 30:361-368.
8. Fox L.M., Saravolatz L.D. Nitazoxanide: a new thiazolide antiparasitic agent. Clin Infect Dis 2005, 40:1173-1180.
9. Diaz E., Mondragon J., Ramirez E., Bernal R. Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico. Am J Trop Med Hyg 2003, 68:384-385.
10. Cabello R.R., Guerrero L.R., Garcia M.R.M., Cruz A.G. Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico. Trans R Soc Trop Med Hyg 1997, 91:701-703.
11. Abaza H., El-Zayadi A., Kabil S.M., Rizk H. Nitazoxanide in the treatment of patients with intestinal protozoan and helminthic infections: a report on 546 patients in Egypt. Curr Ther Res 1998, 59:116-121.
12. Pankuch G.A., Appelbaum P.C. Activities of tizoxanide and nitazoxanide compared to those of five other thiazolides and three other agents against anaerobic species. Antimicrob Agents Chemother 2006, 50:1112-1117.
13. Finegold S.M., Molitoris D., Väisänen M.L. Study of the in vitro activities of rifaximin and comparator agents against 536 anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora. Antimicrob Agents Chemother 2009, 53:281-286.
14. Debreuil L., Houcke I., Mouton Y., Rossignol J.F. In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms. Antimicrob Agents Chemother 1996, 40:2266-2270.
15. Sisson G., Goodwin A., Raudonikiene A., Hughes N.J., Mukhopadhyay A.K., Berg D.E., et al. Identification of enzymes associated with the reductive activation of nitazoxanide, nitrofurans and metronidazole in Helicobacter pylori. Antimicrob Agents Chemother 2002, 46:2116-2123.
16. Hoffman P.S., Sisson G., Croxen M.A., Welch K., Harman W.D., Cremades N., et al. Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni. Antimicrob Agents Chemother 2007, 51:868-876.
17. Rossignol J.F., Abu-Zekry M., Hussein A., Santoro M.G. Effect of nitazoxanide for treatment of severe rotavirus diarrhea: randomized double-blind placebo-controlled trial. Lancet 2006, 368:124-129.
18. Rossignol J.F., La Frazia S., Chiappa L., Ciucci A., Santoro M.G. Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at post-translational level. J Biol Chem 2009, 29798-29808.
19. Elazar M., Liu M., McKenna S., Liu P., Gehrig E.A., Puglisi J.D., et al. The anti-hepatitis C agent nitazoxanide induces phosphorylation of eIF2α via PKR activation. Gastroenterology 2009, 137:1827-1835.
20. Rossignol J.F., El-Gohary Y.M. Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo controlled clinical trial. Aliment Pharmacol Ther 2006, 24:1423-1430.
21. Rossignol J.F., Ayoub A., Ayers M.S. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of nitazoxanide. J Infect Dis 2001, 184:103-106.
22. Rossignol J.F., Ayoub A., Ayers M.S. Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica/dispar: a double blind placebo controlled study of nitazoxanide. J Infect Dis 2001, 184:381-384.
23. Rossignol J.F., Kabil S.M., Said M., Samir H., Younis A.M. Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis. Clin Gastroenterol Hepatol 2005, 3:987-991.
24. Amar C.F., East C.L., Gray J., Iturriza-Gomara M., Maclure E.A., McLauchlin J. Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: re-examination of the English case control Infectious Intestinal Disease Study (1993-1996). Eur J Clin Microbiol Infect Dis 2007, 26:311-323.
25. Patel M.M., Widdowson M.A., Glass R.I., Akazawa K., Vinje J., Parashar U.D. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 2008, 14:1224-1231.
26. de Bruin E., Duizer E., Vennema H., Koopmans M.P.G. Diagnosis of norovirus outbreaks by commercial ELISA or RT-PCR. J Virol Methods 2006, 137:259-264.
27. Morgan U.M., Pallant L., Dwyer B.W., Forbes D.A., Rich G., Thompson R.C.A. Comparison of PCR and microscopy for detection of Cryptosporidium parvum in human fecal specimens: clinical trial. J Clin Microbiol 1998, 36:995-998.
28. Jiang Z.D., DuPont H.L., Brown E.L., Nandy R.K., Ramamurthy T., Sinha A., et al. Microbial etiology of travelers' diarrhea in Mexico, Guatemala, and India: importance of enterotoxigenic Bacteroides fragilis and Arcobacter species. J Clin Microbiol 2010, 48:1417-1419.
29. Sears C.L. Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin Microbiol Rev 2009, 22:349-369.
30. Ortiz J.J., Ayoub A., Gargala G., Lopez-Chegne N., Favennec L. Randomised clinical study of nitazoxanide in the treatment of giardiasis diarrhea in children from Northern Peru. Aliment Pharmacol Ther 2001, 15:1409-1415.
31. Davila-Gutierrez C.E., Vasquez C., Trujillo-Hernandez B., Huerta M. Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children. Am J Trop Med Hyg 2002, 66:251-254.
32. Ortiz J.J., Lopez Chegne N., Gargala G., Favennec L. Comparative clinical studies of nitazoxanide, albendazole, and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from Peru. Trans R Soc Trop Med Hyg 2002, 96:1-4.
33. Teran C.G., Teran-Escalera C.N., Villarroel P. Nitazoxanide vs. probiotics for the treatment of acute rotavirus diarrhea in children: A randomized, single-blind, controlled trial in Bolivian children. Int J Infect Dis 2009, 13:518-523.